CLARITHROMYCIN tablet, film coated

Страна: САЩ

Език: английски

Източник: NLM (National Library of Medicine)

Активна съставка:

CLARITHROMYCIN (UNII: H1250JIK0A) (CLARITHROMYCIN - UNII:H1250JIK0A)

Предлага се от:

Wockhardt Limited

INN (Международно Name):

CLARITHROMYCIN

Композиция:

CLARITHROMYCIN 250 mg

Начин на приложение:

ORAL

Вид предписание :

PRESCRIPTION DRUG

Терапевтични показания:

To reduce the development of drug-resistant bacteria and maintain the effectiveness of clarithromycin tablet and other antibacterial drugs, clarithromycin tablet should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. Clarithromycin tablet is indicated for the treatment of mild to moderate infections caused by susceptible strains of the designated microorganisms in the conditions as listed below: Pharyngitis/Tonsillitis due to Streptococcus pyogenes (The usual drug of choice in the treatment and prevention of streptococcal infections and the prophylaxis of rheumatic fever is penicillin administered by either the intramuscular or the oral route. Clarithromycin is generally effective

Каталог на резюме:

Clarithromycin tablet, USP 250 mg are supplied as white oval film-coated tablets debossed with W954 on one side and other side plain. Bottles of 60 Tablets (NDC 64679-954-01) Clarithromycin tablet, USP 500 mg are supplied as white oval film-coated tablets debossed with W949 on one side and other side plain. Bottles of 60 Tablets (NDC 64679-949-01) Store at 20° - 25°C (68° - 77°F) [See USP Controlled Room Temperature]

Статус Оторизация:

Abbreviated New Drug Application

Данни за продукта

CLARITHROMYCIN- CLARITHROMYCIN TABLET, FILM COATED
WOCKHARDT LIMITED
----------
CLARITHROMYCIN TABLETS, USP
Rx only
To reduce the development of drug-resistant bacteria and maintain the
effectiveness of clarithromycin
tablet and other antibacterial drugs, clarithromycin tablet should be
used only to treat or prevent
infections that are proven or strongly suspected to be caused by
bacteria.
DESCRIPTION
Clarithromycin is a semi-synthetic macrolide antibiotic. Chemically,
it is 6-_0_-methylerythromycin. The
molecular formula is C
H NO , and the molecular weight is 747.95. The structural formula is:
Clarithromycin is a white to off-white crystalline powder. It is
soluble in acetone, slightly soluble in
methanol, ethanol, and acetonitrile, and practically insoluble in
water.
Clarithromycin tablet are available as immediate-release tablets.
Each white oval film-coated immediate-release clarithromycin tablet
contains 250 mg or 500 mg of
clarithromycin and the following inactive ingredients:
250 mg tablets: microcrystalline cellulose, lactose monohydrate,
hydroxypropyl cellulose, sodium
starch glycolate, colloidal silicon dioxide, talc, magnesium stearate,
hypromellose, titanium dioxide,
and polyethylene glycol.
500 mg tablets: microcrystalline cellulose, lactose monohydrate,
hydroxypropyl cellulose, sodium
starch glycolate, colloidal silicon dioxide, talc, magnesium stearate,
hypromellose, titanium dioxide,
and polyethylene glycol.
CLINICAL PHARMACOLOGY
PHARMACOKINETICS
Clarithromycin is rapidly absorbed from the gastrointestinal tract
after oral administration. The absolute
bioavailability of 250 mg clarithromycin tablet was approximately 50%.
For a single 500 mg dose of
clarithromycin, food slightly delays the onset of clarithromycin
absorption, increasing the peak time
38
69
13
clarithromycin, food slightly delays the onset of clarithromycin
absorption, increasing the peak time
from approximately 2 to 2.5 hours. Food also increases the
clarithromycin peak plasma concentration by
about 24%, but does not affect the ext